The malaria drug is quickly falling out of favor with the medical community as a potential treatment for the disease. On the back of mounting concerns about hydroxychloroquine's safety, global pharmaceutical major Sanofi (NASDAQ:SNY) has quit providing it to COVID-19 patients enrolled in its clinical trials for the drug. It has also put a temporary…
A box of Plaquenil, an anti-malaria drug hydroxychloroquine made by Sanofi, used for years to treat malaria and autoimmune disorders.Alain Pitton | NurPhoto | Getty ImagesFrench drugmaker Sanofi said Friday it is suspending recruitment of new patients for its clinical trials looking at anti-malaria drug hydroxychloroquine as a potential treatment for the coronavirus.The company is also…
2 min read Amazon’s Prime Big Deal Days is less than a week away. The event is set to run from Tuesday, October 6 through midnight on Wednesday, October 7. Adidas and Under Armour apparel, a newly discounted set of golf balls, and a very solid TaylorMade golf bag are all deeply discounted. FALL GOLF
You don't have permission to access "http://www.medpagetoday.com/podcasts/healthwatch/123146" on this server. Reference #18.d494d817.1790474508.33970988 https://errors.edgesuite.net/18.d494d817.1790474508.33970988
4 min read WHEN YOU FIND something good, it makes sense to capitalize on it, right? James Gunn’s DC Universe is still in its relative infancy, and its earlygoings have been good, but a bit bumpy. Creature Commandos and the second season of Peacemaker were strong and had their audience, and Superman was very good.
